leighlogan
13 minutes ago
On Thursday, H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Anavex Life Sciences (NASDAQ:AVXL) to $42.00, up from the previous $40.00, while reiterating a Buy rating on the stock. Currently trading at $10.87, the company has demonstrated remarkable momentum with a 28.34% re